GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Novartis AG (XSWX:NOVN) » Definitions » Current Deferred Taxes Liabilities

Novartis AG (XSWX:NOVN) Current Deferred Taxes Liabilities : CHF0 Mil (As of Sep. 2024)


View and export this data going back to 2001. Start your Free Trial

What is Novartis AG Current Deferred Taxes Liabilities?

Current Deferred Taxes Liabilities represent future tax liabilities, resulting from temporary differences between book (accounting) value of assets and liabilities and their tax value, or timing differences between the recognition of gains and losses in financial statements and their recognition in a tax computation. Deferred tax liabilities generally arise where tax relief is provided in advance of an accounting expense, or income is accrued but not taxed until received.

Novartis AG's current deferred tax liabilities for the quarter that ended in Sep. 2024 was CHF0 Mil.

Novartis AG Current Deferred Taxes Liabilities Historical Data

The historical data trend for Novartis AG's Current Deferred Taxes Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Novartis AG Current Deferred Taxes Liabilities Chart

Novartis AG Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Current Deferred Taxes Liabilities
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Novartis AG Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Current Deferred Taxes Liabilities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Novartis AG Current Deferred Taxes Liabilities Related Terms

Thank you for viewing the detailed overview of Novartis AG's Current Deferred Taxes Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.

Novartis AG Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Novartis AG (XSWX:NOVN) » Definitions » Current Deferred Taxes Liabilities
Comparable Companies
XSWX:ROG XSWX:COPN LLY OCSE:NOVO B JNJ ABBV MRK LSE:AZN AMGN PFE XPAR:SAN BMY GILD LSE:GSK TSE:4519 TSE:4568 SHSE:600276 TSE:4578 BIIB XTER:BAYN
Traded in Other Exchanges
NVSEF:USA NVS:USA NVS N:Mexico NOVNz:UK 0K9E:UK 0QLR:UK NOTA:Germany NOTA:Germany NOVNEE:Switzerland N1VS34:Brazil NVS:Argentina
Address
Lichtstrasse 35, Basel, CHE, 4056
Website
https://www.novartis.com
Novartis develops and manufactures innovative drugs. The firm's key areas of drug development include oncology, rare diseases, neuroscience, immunology, respiratory, cardio-metabolic, and established medicines. The company sells its products globally, with the United States comprising close to one third of total revenue.

Novartis AG Headlines

No Headlines